Summary
Background The quality and accessibility of menstrual health education in developing nations, including India, remain inadequate due to challenges such as poverty, social stigma, and gender inequality. While community-driven initiatives aim to raise awareness, artificial intelligence (AI) offers a scalable solution for disseminating accurate information. However, existing general-purpose large language models (LLMs) are ill-suited for this task, suffering from low accuracy, cultural insensitivity, and overly complex responses. To address these limitations, we developed MenstLLaMA, a specialized LLM tailored to the Indian context, designed to deliver menstrual health education empathetically, supportively, and accessible.
Methods We curated a novel, domain-specific dataset and benchmarked state-of-the-art LLMs to develop MenstLLaMA, an empathic companion model. The evaluation employed an open-label benchmark design with a four-stage framework: (1) overlap with ground truth, (2) clinical relevance, (3) response diversity, and (4) user satisfaction. A panel of clinical experts (n=118) conducted expert evaluations, while participants (n=1,200) interacted with chatbots, including MenstLLaMA, in 15–20-minute randomized sessions for user satisfaction assessment.
Findings MenstLLaMA was compared against state-of-the-art general-purpose LLMs such as GPT-4o, Claude-3, and Mistral during the evaluation period using automated and human-based metrics. MenstLLaMA achieved the highest BLEU score (0.059) and BERTScore (0.911), outperforming competitors without requiring few-shot learning. Clinical experts consistently rated its responses superior to gold-standard answers. User case studies revealed high ratings in Understandability (4.7/5) and Relevance (4.3/5), with a moderate rating in Context Sensitivity (3.9/5).
Interpretation MenstLLaMA demonstrates exceptional accuracy, empathy, and user satisfaction in menstrual health education, bridging critical gaps left by general-purpose LLMs. Its potential for integration into broader health education platforms positions it as a transformative tool for menstrual well-being. Future research may explore its long-term impact on public perception and menstrual hygiene practices.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We would like to thank the financial support of the Tower Research Capital Markets toward using machine learning for social good, Rajiv Khemani Young Faculty Chair Professorship in AI, and the equipment support of central HPC facility (Padum).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data supporting the findings of this study are publicly available at Hugging Face. The dataset can be accessed at https://huggingface.co/datasets/proadhikary/MENST.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.